Results 21 to 30 of about 169,457 (393)

Determination of Iridium and Rhodium in Copper Anode Slime by Inductively Coupled Plasma-Mass Spectrometry with Nickel Sulphide Fire Assay

open access: yesYankuang ceshi, 2023
BACKGROUND With the wide application of iridium and rhodium in aerospace, electronics, energy and other fields, it has become a very attractive metal in the world. In China, iridium and rhodium ore resources are relatively scarce with low grade, so it is
LIU Fangmei   +4 more
doaj   +1 more source

Comparing treatment uncertainty for ultra- vs. standard-hypofractionated breast radiation therapy based on in-vivo dosimetry

open access: yesPhysics and Imaging in Radiation Oncology, 2022
Background and purpose: Postoperative ultrahypofractionated radiation therapy (UHFRT) in 5 fractions (fx) for breast cancer patients is as effective and safe as conventionally hypofractionated RT (HFRT) in 15 fx, liberating time for higher-level daily ...
Yawo A.C. Fiagan   +7 more
doaj   +1 more source

Precision of image-guided spinal stereotactic ablative radiotherapy and impact of positioning variables

open access: yesPhysics and Imaging in Radiation Oncology, 2022
Background and purpose: Spinal stereotactic ablative body radiotherapy (SABR) requires high precision. We evaluate the intrafraction motion during cone-beam computed tomography (CBCT) guided SABR with different immobilization techniques.
Charlotte Billiet   +9 more
doaj   +1 more source

Activated chemical bonds in nanoporous and amorphous iridium oxides favor low overpotential for oxygen evolution reaction

open access: yesNature Communications, 2022
To date, the search for active, selective, and stable electrocatalysts for the oxygen evolution reaction (OER) has not ceased and a detailed atomic-level design of the OER catalyst remains an outstanding (if not, compelling) problem. Considerable studies
Sangseob Lee   +3 more
semanticscholar   +1 more source

Evaluation of automated pre-treatment and transit in-vivo dosimetry in radiotherapy using empirically determined parameters

open access: yesPhysics and Imaging in Radiation Oncology, 2020
Background and purpose: First reports on clinical use of commercially automated systems for Electronic Portal Imaging Device (EPID)-based dosimetry in radiotherapy showed the capability to detect important changes in patient setup, anatomy and external ...
Evy Bossuyt   +4 more
doaj   +1 more source

Durability Testing of Low-Iridium PEM Water Electrolysis Membrane Electrode Assemblies

open access: yesJournal of the Electrochemical Society, 2022
Lowering the iridium loading at the anode of proton exchange membrane (PEM) water electrolyzers is crucial for the envisaged GW-scale deployment of PEM water electrolysis.
M. Möckl   +9 more
semanticscholar   +1 more source

Iridium metallene oxide for acidic oxygen evolution catalysis

open access: yesNature Communications, 2021
Exploring new materials is essential in the field of material science. Especially, searching for optimal materials with utmost atomic utilization, ideal activities and desirable stability for catalytic applications requires smart design of materials ...
Qian Dang   +14 more
semanticscholar   +1 more source

In vivo dosimetry for patients with prostate cancer to assess possible impact of bladder and rectum preparation

open access: yesTechnical Innovations & Patient Support in Radiation Oncology, 2020
Purpose/objective: In all treatment sites of our radiotherapy network, in vivo dosimetry (PerFRACTION™) was fully implemented in February 2018. We hypothesized that additional help with bladder and rectum preparation by home nursing would improve ...
Yawo A.C. Fiagan   +6 more
doaj   +1 more source

Supported Iridium‐based Oxygen Evolution Reaction Electrocatalysts ‐ Recent Developments

open access: yesChemCatChem, 2022
The commercialization of acidic proton exchange membrane water electrolyzers (PEMWE) is heavily hindered by the price and scarcity of oxygen evolution reaction (OER) catalyst, i. e. iridium and its oxides.
L. Moriau   +3 more
semanticscholar   +1 more source

A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial)

open access: yesRadiation Oncology, 2018
Background In an oligometastatic setting, metastasis-directed treatment could render patients disease free, possibly for a protracted interval. Stereotactic ablative radiotherapy (SABR) is one of the treatment modalities that can be offered to these ...
Carole Mercier   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy